Cas no 69034-09-9 (2-Bromo-5-(trifluoromethyl)pyrimidine)
2-Bromo-5-(trifluoromethyl)pyrimidine Chemical and Physical Properties
Names and Identifiers
-
- 2-bromo-5-(trifluoromethyl)pyrimidine
- Pyrimidine, 2-bromo-5-(trifluoromethyl)-
- FEAGCADVLQYESC-UHFFFAOYSA-N
- STL556886
- BBL103076
- FCH1328194
- PC53065
- MB13635
- AK313817
- A903107
- CS-0101604
- DTXSID40604728
- TQP1259
- DS-11980
- AKOS023796311
- FT-0745285
- SY248388
- SCHEMBL11403140
- 69034-09-9
- MFCD14702304
- C76181
- DB-074097
- 2-Bromo-5-(trifluoromethyl)pyrimidine
-
- MDL: MFCD14702304
- Inchi: 1S/C5H2BrF3N2/c6-4-10-1-3(2-11-4)5(7,8)9/h1-2H
- InChI Key: FEAGCADVLQYESC-UHFFFAOYSA-N
- SMILES: BrC1=NC=C(C=N1)C(F)(F)F
Computed Properties
- Exact Mass: 225.93536
- Monoisotopic Mass: 225.93535g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 11
- Rotatable Bond Count: 0
- Complexity: 130
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 25.8
- XLogP3: 2.1
Experimental Properties
- Density: 1.807±0.06 g/cm3 (20 oC 760 Torr),
- Boiling Point: 247.2±50.0 oC (760 Torr),
- Flash Point: 103.3±30.1 oC,
- Solubility: Slightly soluble (2.5 g/l) (25 o C),
- PSA: 25.78
2-Bromo-5-(trifluoromethyl)pyrimidine Security Information
- Hazard Statement: H315-H319-H335
- Storage Condition:Inert atmosphere,Store in freezer, under -20°C
2-Bromo-5-(trifluoromethyl)pyrimidine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-QR213-250mg |
2-Bromo-5-(trifluoromethyl)pyrimidine |
69034-09-9 | 95+% | 250mg |
1362CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-QR213-100mg |
2-Bromo-5-(trifluoromethyl)pyrimidine |
69034-09-9 | 95+% | 100mg |
815CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-QR213-200mg |
2-Bromo-5-(trifluoromethyl)pyrimidine |
69034-09-9 | 95+% | 200mg |
718.0CNY | 2021-07-12 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-QR213-50mg |
2-Bromo-5-(trifluoromethyl)pyrimidine |
69034-09-9 | 95+% | 50mg |
261.0CNY | 2021-07-12 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-QR213-1g |
2-Bromo-5-(trifluoromethyl)pyrimidine |
69034-09-9 | 95+% | 1g |
2529.0CNY | 2021-07-12 | |
| abcr | AB528088-250 mg |
2-Bromo-5-(trifluoromethyl)pyrimidine; . |
69034-09-9 | 250MG |
€278.60 | 2023-04-17 | ||
| Apollo Scientific | PC53065-250mg |
2-Bromo-5-(trifluoromethyl)pyrimidine |
69034-09-9 | 95+% | 250mg |
£50.00 | 2025-02-21 | |
| Apollo Scientific | PC53065-1g |
2-Bromo-5-(trifluoromethyl)pyrimidine |
69034-09-9 | 95+% | 1g |
£535.00 | 2023-04-22 | |
| Chemenu | CM254546-1g |
2-Bromo-5-(trifluoromethyl)pyrimidine |
69034-09-9 | 95% | 1g |
$795 | 2021-08-04 | |
| Matrix Scientific | 130600-1g |
2-Bromo-5-(trifluoromethyl)pyrimidine |
69034-09-9 | 1g |
$1494.00 | 2023-09-06 |
2-Bromo-5-(trifluoromethyl)pyrimidine Related Literature
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
-
Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
-
Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
-
Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
Additional information on 2-Bromo-5-(trifluoromethyl)pyrimidine
2-Bromo-5-(trifluoromethyl)pyrimidine (CAS No. 69034-09-9): An Overview of Its Properties, Applications, and Recent Research
2-Bromo-5-(trifluoromethyl)pyrimidine (CAS No. 69034-09-9) is a versatile compound that has gained significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structure, which includes a bromine atom and a trifluoromethyl group attached to a pyrimidine ring. The combination of these functional groups imparts specific chemical and biological properties that make it an attractive candidate for various applications.
The pyrimidine ring is a fundamental building block in nucleic acids and many other biologically active molecules. The presence of the bromine atom and the trifluoromethyl group in 2-Bromo-5-(trifluoromethyl)pyrimidine enhances its reactivity and stability, making it a valuable intermediate in the synthesis of more complex molecules. The trifluoromethyl group, in particular, is known for its electron-withdrawing properties, which can influence the compound's reactivity and biological activity.
Recent research has focused on the use of 2-Bromo-5-(trifluoromethyl)pyrimidine as a key intermediate in the synthesis of novel pharmaceuticals. One notable application is in the development of anticancer drugs. Studies have shown that compounds derived from 2-Bromo-5-(trifluoromethyl)pyrimidine exhibit potent antiproliferative activity against various cancer cell lines. For example, a study published in the Journal of Medicinal Chemistry reported that a series of pyrimidine derivatives containing the trifluoromethyl group demonstrated significant inhibition of tumor growth in both in vitro and in vivo models.
In addition to its potential in cancer therapy, 2-Bromo-5-(trifluoromethyl)pyrimidine has also been explored for its antiviral properties. Research conducted by a team at the University of California, San Francisco, found that certain derivatives of this compound showed promising activity against several RNA viruses, including influenza and hepatitis C virus. The bromine atom and trifluoromethyl group were found to play crucial roles in enhancing the antiviral efficacy of these derivatives.
The synthetic versatility of 2-Bromo-5-(trifluoromethyl)pyrimidine has also made it an important tool in combinatorial chemistry. Combinatorial approaches allow for the rapid synthesis and screening of large libraries of compounds, which can significantly accelerate drug discovery processes. By using 2-Bromo-5-(trifluoromethyl)pyrimidine as a starting material, researchers can efficiently generate diverse chemical structures with potential therapeutic applications.
From a safety perspective, 2-Bromo-5-(trifluoromethyl)pyrimidine is generally considered to be stable under normal laboratory conditions. However, like many organic compounds, it should be handled with appropriate care to avoid exposure to skin or inhalation. Proper storage and handling procedures should be followed to ensure safety.
In conclusion, 2-Bromo-5-(trifluoromethyl)pyrimidine (CAS No. 69034-09-9) is a multifaceted compound with significant potential in various areas of medicinal chemistry and pharmaceutical research. Its unique structure and chemical properties make it an invaluable intermediate for the synthesis of novel drugs with diverse therapeutic applications. Ongoing research continues to uncover new possibilities for this compound, further solidifying its importance in the field.
69034-09-9 (2-Bromo-5-(trifluoromethyl)pyrimidine) Related Products
- 1785427-17-9(Pyrimidine, 2-bromo-5-(difluoromethyl)-)
- 176214-12-3(5-(Trifluoromethyl)pyrimidine)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)